Population-based study on practice variation regarding preoperative systemic chemotherapy in patients with colorectal liver metastases and impact on short-term outcomes

A.K.E. Elfrink, N.F.M. Kok, L.R. van der Werf, M.F. Krul, E. Marra, M.W.J.M. Wouters, C. Verhoef, K.F.D. Kuhlmann, M. den Dulk, R.J. Swijnenburg, W.W. te Riele, P.B. van den Boezem, W.K.G. Leclercq, D.J. Lips, V.B. Nieuwenhuijs, P.D. Gobardhan, H.H. Hartgrink, C.I. Buis, D.J. Grunhagen, J.M. KlaaseDutch Hepato Biliary Audit Group

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1742-1755
Number of pages14
JournalEuropean Journal of Surgical Oncology
Volume46
Issue number9
DOIs
Publication statusPublished - 1 Sep 2020

Keywords

  • cancer
  • cetuximab
  • colorectal liver metastases
  • hepatectomy
  • hepatotoxicity
  • hospital variation
  • neoadjuvant chemotherapy
  • perioperative chemotherapy
  • postoperative outcomes
  • preoperative chemotherapy
  • resectability
  • resection
  • surgery
  • therapy
  • SURGERY
  • RESECTABILITY
  • Colorectal liver metastases
  • CANCER
  • Preoperative chemotherapy
  • THERAPY
  • NEOADJUVANT CHEMOTHERAPY
  • Surgery
  • PERIOPERATIVE CHEMOTHERAPY
  • HEPATECTOMY
  • RESECTION
  • Hospital variation
  • Postoperative outcomes
  • CETUXIMAB
  • HEPATOTOXICITY

Cite this